Free Trial

Healthpeak Properties (NYSE:DOC) PT Set at $21.00 by Robert W. Baird

Healthpeak Properties logo with Finance background

Key Points

  • Robert W. Baird has lowered its price target for Healthpeak Properties (NYSE:DOC) from $22.00 to $21.00, maintaining an "outperform" rating.
  • Other analysts have also reduced their price targets, with Scotiabank lowering it to $19.00 and Wells Fargo setting a target of $20.00.
  • Despite these downgrades, Healthpeak Properties has a consensus rating of "Moderate Buy" and a consensus price target of $23.00 from the analysts surveyed.
  • MarketBeat previews top five stocks to own in September.

Healthpeak Properties (NYSE:DOC - Get Free Report) has been given a $21.00 price objective by stock analysts at Robert W. Baird in a note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has an "outperform" rating on the real estate investment trust's stock. Robert W. Baird's target price points to a potential upside of 25.02% from the stock's current price.

Other research analysts also recently issued research reports about the company. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Argus reiterated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Wedbush lowered their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their target price for the company from $21.00 to $19.00 in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $23.00.

Get Our Latest Research Report on DOC

Healthpeak Properties Stock Down 0.8%

NYSE:DOC traded down $0.14 during trading hours on Wednesday, reaching $16.80. 2,010,175 shares of the stock were exchanged, compared to its average volume of 5,920,715. The stock has a market cap of $11.67 billion, a PE ratio of 70.03, a PEG ratio of 2.20 and a beta of 1.03. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.35. Healthpeak Properties has a twelve month low of $16.64 and a twelve month high of $23.26. The firm has a 50 day moving average of $17.69 and a 200 day moving average of $18.77.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. The business's quarterly revenue was down .2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.45 earnings per share. On average, equities analysts expect that Healthpeak Properties will post 1.86 earnings per share for the current year.

Insiders Place Their Bets

In other Healthpeak Properties news, Director Tommy G. Thompson acquired 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director directly owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Scott M. Brinker acquired 2,930 shares of the stock in a transaction dated Thursday, July 31st. The stock was acquired at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the purchase, the chief executive officer directly owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 20,030 shares of company stock worth $346,519. Corporate insiders own 0.23% of the company's stock.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Machina Capital S.A.S. boosted its stake in Healthpeak Properties by 62.8% during the first quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock valued at $751,000 after buying an additional 14,336 shares during the last quarter. Douglas Lane & Associates LLC boosted its stake in Healthpeak Properties by 8.5% during the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock valued at $56,471,000 after buying an additional 218,395 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Healthpeak Properties by 6.9% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock valued at $7,229,000 after purchasing an additional 23,135 shares during the last quarter. Ibex Wealth Advisors purchased a new position in shares of Healthpeak Properties in the 1st quarter worth approximately $5,056,000. Finally, Vert Asset Management LLC boosted its holdings in shares of Healthpeak Properties by 6.9% in the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after purchasing an additional 20,924 shares during the period. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines